Metabolic and hormonal pathways, particularly in the growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis, are essential for metabolic regulation of bone and muscle mass, with the decline in GH and IGF-1 levels associated with both osteoporosis and sarcopenia [32]. This evidence concerns the gene IGF1 and sarcopenia.